Schedule of Analyst / Institutional Investors' Meet
Zydus Wellness Ltd has informed BSE regarding "Schedule of Analyst / Institutional Investors' Meet".12-05-2016
Schedule of Analyst / Institutional Investors' Meet
Zydus Wellness Ltd has informed BSE regarding "Schedule of Analyst / Institutional Investors' Meet".Board Intimation for Results & Closure of Trading Window
Zydus Wellness Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held on May 12, 2016 to consider apart from other agenda items to approve the audited financial results for the quarter / year ended on March 31, 2016.Further, as per code of conduct for prevention of Insider Trading adopted by the Company under SEBI [Prohibition of Insider Trading] Regulations, 2015, the Trading Window will remain closed...Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended March 31, 2016
Zydus Wellness Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.Shareholding for the Period Ended March 31, 2016
Zydus Wellness Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2016. For more details, kindly Click hereFDA nod for Zydus arm's drug
Drug maker, Cadila Healthcare Limited (Zydus CAdila) on Wednesday informed that Nesher Pharmaceuticals, an arm of Zydus Pharmaceuticals USA has received its first Abbreviated New Drug Application (AN...Zydus acquires gastro drug 'Actibile' from Kolkata-based Albert David
This is the Group's second acquisition this year after it had acquired select brands of Zoetis in JanuaryZydus Pharma Inc recalls 9,504 bottles of Risperidone tablets
The USFDA said the reason for recall is 'out of specification for a known degradant'Fixes Record Date for Interim Dividend
Zydus Wellness Ltd has informed BSE that the Company has fixed March 17, 2016 as the Record Date for the purpose of Payment of Interim Dividend.Further, the interim dividend shall be paid to the shareholders entitled thereto, on and from, March 21, 2016.Board declares Interim Dividend
Zydus Wellness Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 04, 2016, has approved payment of interim dividend @ of 65% i.e. Rs. 6.5/- per equity share on 3,90,72,089 Equity Shares of Rs. 10/- each of the Company for the financial year 2015-2016.